Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Gross Margin 2010-2025 | AMRX

Current and historical gross margin for AMNEAL PHARMACEUTICALS, INC (AMRX) over the last 10 years. The current gross profit margin for AMNEAL PHARMACEUTICALS, INC as of March 31, 2025 is %.
  
AMNEAL PHARMACEUTICALS, INC Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $2.83B $1.04B 36.71%
2024-12-31 $2.79B $1.02B 36.54%
2024-09-30 $2.68B $0.95B 35.37%
2024-06-30 $2.60B $0.91B 35.07%
2024-03-31 $2.50B $0.88B 35.31%
2023-12-31 $2.39B $0.82B 34.29%
2023-09-30 $2.39B $0.85B 35.44%
2023-06-30 $2.31B $0.81B 34.89%
2023-03-31 $2.27B $0.79B 34.67%
2022-12-31 $2.21B $0.79B 35.47%
2022-09-30 $2.14B $0.74B 34.39%
2022-06-30 $2.12B $0.74B 34.90%
2022-03-31 $2.10B $0.75B 35.83%
2021-12-31 $2.09B $0.77B 36.72%
2021-09-30 $2.07B $0.77B 37.25%
2021-06-30 $2.06B $0.71B 34.27%
2021-03-31 $1.99B $0.64B 32.06%
2020-12-31 $1.99B $0.63B 31.51%
2020-09-30 $1.88B $0.57B 30.37%
2020-06-30 $1.74B $0.49B 28.23%
2020-03-31 $1.68B $0.45B 26.92%
2019-12-31 $1.63B $0.35B 21.65%
2019-09-30 $1.73B $0.44B 25.19%
2019-06-30 $1.83B $0.58B 31.84%
2019-03-31 $1.83B $0.65B 35.66%
2018-12-31 $1.66B $0.72B 43.05%
2018-09-30 $1.50B $0.77B 51.07%
2018-06-30 $1.28B $0.70B 54.81%
2018-03-31 $1.13B $0.65B 57.51%
2017-12-31 $1.03B $0.53B 50.97%
2017-09-30 $1.09B $0.87B 79.84%
2017-06-30 $1.06B $0.57B 53.67%
2017-03-31 $0.98B $0.52B 53.22%
2016-12-31 $1.02B $0.60B 58.68%
2016-09-30 $0.91B $0.13B 13.86%
2016-06-30 $0.90B $0.39B 42.68%
2016-03-31 $0.94B $0.40B 42.10%
2015-12-31 $0.86B $0.35B 41.05%
2015-09-30 $0.71B $0.30B 42.17%
2015-06-30 $0.65B $0.29B 44.74%
2015-03-31 $0.62B $0.31B 50.65%
2014-12-31 $0.60B $0.31B 52.52%
2014-09-30 $0.57B $0.29B 50.53%
2014-06-30 $0.54B $0.25B 46.21%
2014-03-31 $0.48B $0.20B 41.20%
2013-12-31 $0.51B $0.20B 38.87%
2013-09-30 $0.55B $0.23B 41.49%
2013-06-30 $0.57B $0.26B 45.84%
2013-03-31 $0.60B $0.28B 46.26%
2012-12-31 $0.58B $0.28B 48.63%
2012-09-30 $0.60B $0.30B 49.33%
2012-06-30 $0.57B $0.28B 48.95%
2012-03-31 $0.53B $0.26B 49.25%
2011-12-31 $0.51B $0.26B 50.39%
2011-09-30 $0.45B $0.23B 51.10%
2011-06-30 $0.64B $0.33B 51.72%
2011-03-31 $0.67B $0.35B 53.23%
2010-12-31 $0.88B $0.54B 61.32%
2010-09-30 $0.96B $0.58B 60.25%
2010-06-30 $0.72B $0.45B 63.04%
2010-03-31 $0.62B $0.40B 64.15%
2009-12-31 $0.36B $0.19B 52.51%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.476B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.977B 26.85
Takeda Pharmaceutical (TAK) Japan $47.379B 9.42
Daiichi Sankyo, - (DSNKY) Japan $45.180B 23.16
BeOne Medicines - (ONC) Cayman Islands $27.838B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.876B 0.00
Merck (MKKGY) Germany $16.572B 12.14
Summit Therapeutics (SMMT) United States $14.742B 0.00
Shionogi (SGIOY) Japan $14.496B 14.52
United Therapeutics (UTHR) United States $12.940B 11.45
Neurocrine Biosciences (NBIX) United States $12.359B 42.33
Orion OYJ (ORINY) Finland $10.283B 27.81
IPSEN (IPSEY) France $10.093B 0.00
Corcept Therapeutics (CORT) United States $7.619B 61.94
Stevanato Group S.p.A (STVN) Italy $7.299B 44.63
Madrigal Pharmaceuticals (MDGL) United States $6.208B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.911B 0.00
Hypermarcas (HYPMY) Brazil $3.177B 20.90
Crinetics Pharmaceuticals (CRNX) United States $2.888B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.832B 9.92
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.967B 0.00
Indivior (INDV) United States $1.899B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $1.683B 0.00
ARS Pharmaceuticals (SPRY) United States $1.456B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.234B 0.00
Harrow (HROW) United States $1.116B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.069B 21.38
Verve Therapeutics (VERV) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $0.946B 5.10
Akebia Therapeutics (AKBA) United States $0.919B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Ardelyx (ARDX) United States $0.849B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Xencor (XNCR) United States $0.591B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.33
Altimmune (ALT) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.530B 0.00
Relay Therapeutics (RLAY) United States $0.525B 0.00
Bioventus (BVS) United States $0.522B 13.23
AleAnna (ANNA) United States $0.491B 0.00
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Tourmaline Bio (TRML) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.450B 9.40
Oruka Therapeutics (ORKA) United States $0.448B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Savara (SVRA) United States $0.353B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 9.26
Liminatus Pharma (LIMN) United States $0.333B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.22
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
ProKidney (PROK) United States $0.251B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Esperion Therapeutics (ESPR) United States $0.216B 0.00
MediWound (MDWD) Israel $0.214B 0.00
OmniAb (OABI) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Aclaris Therapeutics (ACRS) United States $0.152B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.151B 0.00
Journey Medical (DERM) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 18.30
Nektar Therapeutics (NKTR) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.087B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Surrozen (SRZN) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
FibroGen (FGEN) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00